Qingdao Vland Biotech Management
Management criteria checks 2/4
Qingdao Vland Biotech's CEO is Gang Chen, appointed in May 2014, has a tenure of 10.67 years. directly owns 2.84% of the company’s shares, worth CN¥80.74M. The average tenure of the management team and the board of directors is 8 years and 4.7 years respectively.
Key information
Gang Chen
Chief executive officer
CN¥1.5m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 10.7yrs |
| CEO ownership | 2.8% |
| Management average tenure | 8yrs |
| Board average tenure | 4.7yrs |
Recent management updates
Recent updates
Why Investors Shouldn't Be Surprised By Qingdao Vland Biotech INC.'s (SHSE:603739) 28% Share Price Surge
Nov 08
Qingdao Vland Biotech's (SHSE:603739) Anemic Earnings Might Be Worse Than You Think
Nov 04Some Qingdao Vland Biotech INC. (SHSE:603739) Shareholders Look For Exit As Shares Take 27% Pounding
Sep 05Qingdao Vland Biotech INC.'s (SHSE:603739) Popularity With Investors Under Threat As Stock Sinks 26%
Jun 07Investors Shouldn't Be Too Comfortable With Qingdao Vland Biotech's (SHSE:603739) Earnings
May 06Qingdao Vland Biotech INC. (SHSE:603739) Might Not Be As Mispriced As It Looks
Apr 16CEO
Gang Chen (49 yo)
10.7yrs
Tenure
CN¥1,470,700
Compensation
Mr. Gang Chen is Chairman of Qingdao Vland Biotech INC. from May 17, 2023 and General Manager and Director of Qingdao Vland Biotech INC. from May 12, 2014.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Chairman | 10.7yrs | CN¥1.47m | 2.84% CN¥ 80.7m | |
| CFO & Director | 10.2yrs | CN¥1.02m | 0.22% CN¥ 6.3m | |
| Board Secretary | 5.8yrs | CN¥480.60k | 0.033% CN¥ 943.4k | |
| Deputy General Manager | 1.7yrs | CN¥360.70k | 0.041% CN¥ 1.2m |
8.0yrs
Average Tenure
45.5yo
Average Age
Experienced Management: 603739's management team is seasoned and experienced (8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Chairman | 10.7yrs | CN¥1.47m | 2.84% CN¥ 80.7m | |
| CFO & Director | 1.7yrs | CN¥1.02m | 0.22% CN¥ 6.3m | |
| Director | 13.7yrs | CN¥300.70k | 3.74% CN¥ 106.4m | |
| Independent Director | 4.7yrs | CN¥60.00k | no data | |
| Supervisor | 4.7yrs | no data | no data | |
| Chairman of Supervisory Board | 4.7yrs | no data | no data | |
| Employee Representative Supervisor | 4.7yrs | no data | no data | |
| Independent Director | 1.7yrs | CN¥40.00k | no data |
4.7yrs
Average Tenure
45.5yo
Average Age
Experienced Board: 603739's board of directors are considered experienced (4.7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 04:31 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Qingdao Vland Biotech INC. is covered by 3 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jiarui Lu | Guosen Securities Co., Ltd. |
| Hairong Liu | Minsheng Securities Co. |
| Xuemei Yao | Zhongtai Securities Co. Ltd. |